Close Menu

The editor-in-chief of Science decries Pfizer's subpoena served on the New England Journal of Medicine. Pfizer is being sued by plaintiffs who say that Celebrex and Bextra cause cardiovascular and other injuries, and some of them may point to NEJM papers to back up their claims. Pfizer, then, wants to look through the confidential peer-reviews of those, saying the public has no interest in protecting the editorial process of a journal.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.